Caterina Bartolotta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Caterina Bartolotta has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Carmela Zizzo
Institute of Biomedicine and Molecular Immunology "A. Monroy", National Research Council, Palermo, Italy
1 shared publication - Federica Pizzo
CNR-IBIM: Institute of Biomedicine and Molecular Immunology “A. Monroy”, Via Ugo la Malfa n.153, Palermo, Italy
1 shared publication - Francesco Iemolo
CNR-IBIM: Institute of Biomedicine and Molecular Immunology “A. Monroy”, Via Ugo la Malfa n.153, Palermo, Italy
1 shared publication - Giovanni Duro
Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), 90146 Palermo, Italy
1 shared publication - Giuseppe Albeggiani
CNR-IBIM: Institute of Biomedicine and Molecular Immunology “A. Monroy”, Via Ugo la Malfa n.153, Palermo, Italy
1 shared publication - Paolo Colomba
Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), 90146 Palermo, Italy
1 shared publication
Latest Publications
- Open Access
- 7 January 2014
- Published by Springer Nature in BMC Research Notes
- Vol. 7 (1) , 11
De novo mutation in a male patient with Fabry disease: a case report
Fabry disease is an X-linked inherited metabolic condition where the deficit of the α-galactosidase A enzyme, encoded by the GLA gene, leads to glycosphingolipid storage, mainly globotriaosylceramide. To date, more than 600 mutations have been identified in human GLA gene that are responsible for FD, including missense and nonsense mutations, small and large deletions. Such mutations are usually inherited, and cases of de novo onset occur rarely.
- 7 January 2014
- Published by Springer Nature in BMC Research Notes
- Vol. 7 (1) , 11
Open AccessDe novo mutation in a male patient with Fabry disease: a case report
Fabry disease is an X-linked inherited metabolic condition where the deficit of the α-galactosidase A enzyme, encoded by the GLA gene, leads to glycosphingolipid storage, mainly globotriaosylceramide. To date, more than 600 mutations have been identified in human GLA gene that are responsible for FD, including missense and nonsense mutations, small and large deletions. Such mutations are usually inherited, and cases of de novo onset occur rarely.